EPIDEMIOLOGICAL STUDIES ON VARYING EXTENDED-SPECTRUM β-LACTAMASES PRODUCING UROPATHOGENIC BACTERIA
Keywords:
Uropathogens, E coli, ESBL, Hospital acquired infectionAbstract
Objective: Urinary tract infection (UTI) is the most common serious infection during infancy, adult male and female, as well as at the time of pregnancy. UTI is also the most common nosocomial infection in many hospitals and accounts for approximately 35% of all hospital acquired infections. Hence the present study was aimed to screen the presence of multi-drug resistant bacterial pathogens among the urine samples collected from in and out patients of multi-speciality hospital.
Methods: Standard microbiological laboratory protocols were followed and about 152 samples were processed and screened. Among them, 49 reported positive for the presence of urinary bacterial pathogens.
Results: Among 49 isolates, Escherichia coli registered its prevalence in about 44 samples followed by Klebsiella spp. (4) and Pseudomones spp. (1). The gender wise distribution was found to be more among female patients (42%) than male patients (24%). The age wise distribution of infection among male and female patients was also noticed. Further, the multi-drug resistance of the isolates was done by using 8 antibiotics.
Conclusion: All the isolates exhibited the multiple antibiotic resistance and the isolates showed 27 different antibiotic resistance patterns. This confirms the prevalence of ESBL producers among the urinary pathogens.
Downloads
References
Akram M, Shaid M, Khan AU. Etiology and antibiotic resistance patterns of community acquired urinary tract infection in JNNC Hospital Aligarh. India Ann Clin Microbiol Antimicrob 2007;6(1):4.
Behzadi P, Behzadi E. The microbial agents of urinary tract infections at central laboratory of Shariati Hospital, Tehran, IRAN. Turk Klin Tip Bilim 2008;28:445-9.
Burt CW, Schappert SM. Ambulatory care visits to physician offices, hospital outpatients departments, and emergency departments: United States. Vital Health Stat 2004;13:1-70.
Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother 1995;39:1211-33.
Dayan N, Dabbah H, Weissman I, Aga I, Even L, Glikman D. Urinary tract infections caused by community-acquired extended-spectrum β-lactamase-producing and nonproducing bacteria: A comparative study. J Pediatr 2013;163:1417-21.
Dimitrov TS, Udo EE, Emara M, Awni F, Passadilla R. Etiology and antibiotic susceptibility patterns of community acquired urinary tract Infections in a Kuwait hospital. Med Pri Prac 2013;13(6):334-9.
Fadel R, Dakdouki GK, Kanafani ZA, Araj GF, Kanj SS. Clinical and microbiological profile of urinary tract infection at a tertiary-care center in Lebanon. Infect Control Hosp Epidemiol 2004;25:82-5.
Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis 2011;52:103-20.
Hasan AS, Nair D, Kaur J, Baweja G, Deb M, Aggarwal P. Resistance patterns of urinary isolates in a Tertiary Indian Hospital. J Ayub Med Coll Abbottabad 2007;19(1):39-41.
Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, Alejandria M, et al. Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 2011;63:114-23.
Ishikawa K, Matsumoto T, Yasuda M, Uehara S, Muratani T, Yagisawa M, et al. The nationwide study of bacterial pathogens associated with urinary tract infections conducted by the Japanese Society of Chemotherapy. J Infect Chemother 2011;17:126-38.
Jain S, Sharma S, Kumar M, Shree N, Sharma Y. Prevalence of uropathogens in urinary tract infection and their antimicrobial resistance pattern in a North Delhi hospital, India: A nine year study. Int J Microbiol Res 2014;6(1):545-52.
Jain S, Soni R, Bhuyar G, Shah H. Prevalence of uropathogens in various age groups and their resistance pattern in a tertiary care hospital in Central India. Nat J Integ Res Med 2011;2(4):7-10.
Jalalpoor Sh, Kasra Kermanshahi R, Nouhi AS, Zarkesh E. Survey frequencies of β-lactamase enzyme and antibiotic sensitivity pattern in isolated pathogen bacteria from low and high hospital contact surfaces. Pajuhandeh J 2010;15:77-82.
Khan SH, Feroz F, Noor R. Study of extended-spectrum β-lactamase-producing bacteria from urinary tract infections in Bangladesh. Tzu Chi Med J 2013;25:39-42.
Kolawole AS, Kolawole OM, Kandaki-Olukemi YT, Babatunde SK, Durowade KA, Kolawole CF. Prevalence of urinary tract infections (UTI) among patients attending. Sci Res Essays 2009;1:163-7.
Kothari A, Sagar V. Antibiotic resistance in pathogens causing community-acquired urinary tract infections in India: a multicenter study. J Infect Developing Countries 2008;2:354-8.
Manikandan S, Ganesapandian S, Singh M, Kumaraguru AK. Antimicrobial susceptibility pattern of urinary tract infection causing human pathogenic bacteria. Asian J Med Sci 2011;3(2):56-60.
Mohammed A, Mohammed S, Asad UK. Etiology and antibiotic resistance patterns of community acquired urinary tract infections in JNMC Hospital, Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:6.
Moraes D, Braoios A, Alves JLB, daCosta RM. Prevalence of uropathogens and antimicrobial susceptibility profile in outpatient from JataÃ-GO. J Bras Patol Med Lab 2014;50(3):200-04.
Murugan K, Savitha T, Vasanthi S. Retrospective study of antibiotic resistance among uropathogens from rural teaching hospital, Tamilnadu, India. Asian Pac J Trop Dis 2012;2(5):375-80.
Naber KG. Use of quinolones in urinary tract infections and prostatitis. Rev Infect Dis 1989;11(5):1321.
Omigie O, Okoror L, Umolu P, Ikuuh G. Increasing resistance to quinolones: a four-year prospective study of urinary tract infection pathogens. Int J Gen Med 2009;2:171-5.
Qi C, Pilla V, Yu JH, Reed K. Changing prevalence of Escherichia coli with CTX-M-type extended-spectrum b-lactamases in outpatient urinary E. coli between 2003 and 2008. Diagn Microbiol Infect Dis 2010;67:87-91.
Ram S, Gupta R, Gaheer M. Emerging antibiotic resistance among the uropathogens. Indian J Med Sci 2000;54(9):388-94.
Raz R, Gennesin Y, Wasser J, Stoler Z, Rosenfeld S, Rottensterich E, et al. Recurrent urinary tract infections in postmenopausal women. Clin Infect Dis 2000;30:152-6.
Stratchounski LS, Rafalski VV. Antimicrobial susceptibility of pathogens isolated from adult patients with uncomplicated community-acquired urinary tract infections in the Russian Federation: two multicentre studies, UTIAP-1 and UTIAP-2. Int J Antimicrob Agents 2000;28(1):4-9.
Taneja N, Rao P, Arora J, Ashok DA. Occurrence of ESBL and Amp-C ß-lactamases and susceptibility to newer antimicrobial agents in complicated UTI. Indian J Med Res 2008;127:85-8.
Tankhiwale SS, Jalgaonkar SV, Ahamad S, Hassani U. Evaluation of extended spectrum beta lactamase in urinary isolates. Indian J Med Res 2004;120:553-6.
Noor AF, Shams F, Munshi SK, Hassan M, Noor R. Prevalence and antibiogram profile of uropathogens isolated from hospital and community patients with urinary tract infections in Dhaka city. J Bangl Aca Sci 2013;37(1):57-63.
Wu Y, Chen P, Hung Y, Ko W. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect 2014;47;197-203.